Status:
UNKNOWN
Prognosis of Patients With Acute-on-chronic Liver Failure
Lead Sponsor:
Xiangya Hospital of Central South University
Conditions:
Acute-On-Chronic Liver Failure
Eligibility:
All Genders
18-80 years
Brief Summary
Patients with Acute on Chronic Liver Failure (ACLF) have high short-term mortality. The use of a severity score could define the patient's prognosis. This study mainly prospectively analyze the clinic...
Detailed Description
Patients with Acute on Chronic Liver Failure (ACLF) have high short-term mortality. The use of a severity score could define the patient's prognosis and would help determine in whom the treatment is e...
Eligibility Criteria
Inclusion
- patients with evidence of chronic liver disease patients with liver failure
Exclusion
- Patients who do not have chronic liver disease Patients who have hepatocellular carcinoma Patients who admitted for extrahepatic manifestations Patients who have HIV infection Patients who admitted for symptomatic control of chronic liver disease, other than acute deterioration of liver function
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05393453
Start Date
June 1 2022
End Date
June 1 2025
Last Update
June 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xiangya Hospital
Changsha, Hunan, China, 410000